These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 30959235)

  • 21. Immune changes and neurotransmitters: possible interactions in depression?
    Sperner-Unterweger B; Kohl C; Fuchs D
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():268-76. PubMed ID: 23085509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tryptophan catabolism in females with irritable bowel syndrome: relationship to interferon-gamma, severity of symptoms and psychiatric co-morbidity.
    Fitzgerald P; Cassidy Eugene M; Clarke G; Scully P; Barry S; Quigley Eamonn MM; Shanahan F; Cryan J; Dinan Timothy G
    Neurogastroenterol Motil; 2008 Dec; 20(12):1291-7. PubMed ID: 18823288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of electroconvulsive therapy on the tryptophan-kynurenine metabolic pathway.
    Guloksuz S; Arts B; Walter S; Drukker M; Rodriguez L; Myint AM; Schwarz MJ; Ponds R; van Os J; Kenis G; Rutten BP
    Brain Behav Immun; 2015 Aug; 48():48-52. PubMed ID: 25765557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferon-gamma Mediated Metabolic Pathways in Hospitalized Patients During Acute and Reconvalescent COVID-19.
    Gietl M; Burkert F; Seiwald S; Böhm A; Hofer S; Gostner JM; Piater T; Geisler S; Weiss G; Loeffler-Ragg J; Sonnweber T; Tancevski I; Pizzini A; Sahanic S; Fuchs D; Bellmann-Weiler R; Kurz K
    Int J Tryptophan Res; 2023; 16():11786469231154244. PubMed ID: 37038445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tryptophan metabolism, its relation to inflammation and stress markers and association with psychological and cognitive functioning: Tasmanian Chronic Kidney Disease pilot study.
    Karu N; McKercher C; Nichols DS; Davies N; Shellie RA; Hilder EF; Jose MD
    BMC Nephrol; 2016 Nov; 17(1):171. PubMed ID: 27832762
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms.
    Schefold JC; Zeden JP; Fotopoulou C; von Haehling S; Pschowski R; Hasper D; Volk HD; Schuett C; Reinke P
    Nephrol Dial Transplant; 2009 Jun; 24(6):1901-8. PubMed ID: 19155537
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tryptophan metabolism in post-withdrawal alcohol-dependent patients.
    Gleissenthall GV; Geisler S; Malik P; Kemmler G; Benicke H; Fuchs D; Mechtcheriakov S
    Alcohol Alcohol; 2014; 49(3):251-5. PubMed ID: 24644258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cross-sectional relationship between kynurenine pathway metabolites and cognitive function in major depressive disorder.
    Zhou Y; Zheng W; Liu W; Wang C; Zhan Y; Li H; Chen L; Ning Y
    Psychoneuroendocrinology; 2019 Mar; 101():72-79. PubMed ID: 30419374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of PEG-interferon alpha plus ribavirin on tryptophan metabolism in patients with chronic hepatitis C.
    Comai S; Cavalletto L; Chemello L; Bernardinello E; Ragazzi E; Costa CV; Bertazzo A
    Pharmacol Res; 2011 Jan; 63(1):85-92. PubMed ID: 20940053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolomic changes demonstrate reduced bioavailability of tyrosine and altered metabolism of tryptophan via the kynurenine pathway with ingestion of medical foods in phenylketonuria.
    Ney DM; Murali SG; Stroup BM; Nair N; Sawin EA; Rohr F; Levy HL
    Mol Genet Metab; 2017 Jun; 121(2):96-103. PubMed ID: 28400091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antidepressant effect of repeated ketamine administration on kynurenine pathway metabolites in patients with unipolar and bipolar depression.
    Zhou Y; Zheng W; Liu W; Wang C; Zhan Y; Li H; Chen L; Li M; Ning Y
    Brain Behav Immun; 2018 Nov; 74():205-212. PubMed ID: 30213652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tryptophan and Kynurenine Levels and Its Association With Sleep, Nonphysical Fatigue, and Depression in Chronic Hemodialysis Patients.
    Malhotra R; Persic V; Zhang W; Brown J; Tao X; Rosales L; Thijssen S; Finkelstein FO; Unruh ML; Ikizler A; Garimella PS; Ix JH; Kooman J; Levin NW; Handelman GJ; Kotanko P
    J Ren Nutr; 2017 Jul; 27(4):260-266. PubMed ID: 28366444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Kynurenine pathway changes in late-life depression.
    Wu Y; Zhong X; Mai N; Wen Y; Shang D; Hu L; Chen B; Zhang M; Ning Y
    J Affect Disord; 2018 Aug; 235():76-81. PubMed ID: 29655078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tryptophan degradation increases with stage in patients with rheumatoid arthritis.
    Schroecksnadel K; Winkler C; Duftner C; Wirleitner B; Schirmer M; Fuchs D
    Clin Rheumatol; 2006 May; 25(3):334-7. PubMed ID: 16261283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Kynurenine pathway changes in late-life depression with memory deficit.
    Wu Y; Mai N; Zhong X; Wen Y; Zhou Y; Li H; Shang D; Hu L; Chen X; Chen B; Zhang M; Ning Y
    Psychiatry Res; 2018 Nov; 269():45-49. PubMed ID: 30145300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of experimental diabetes on brain levels of monoamine neurotransmitters and their precursor amino acids during tryptophan loading.
    Masiello P; Balestreri E; Bacciola D; Bergamini E
    Acta Diabetol Lat; 1987; 24(1):43-50. PubMed ID: 2887079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity.
    Wichers MC; Koek GH; Robaeys G; Verkerk R; Scharpé S; Maes M
    Mol Psychiatry; 2005 Jun; 10(6):538-44. PubMed ID: 15494706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma tryptophan and five other amino acids in depressed and normal subjects.
    DeMyer MK; Shea PA; Hendrie HC; Yoshimura NN
    Arch Gen Psychiatry; 1981 Jun; 38(6):642-6. PubMed ID: 7247626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new method for rapidly and simultaneously decreasing serotonin and catecholamine synthesis in humans.
    Leyton M; Pun VK; Benkelfat C; Young SN
    J Psychiatry Neurosci; 2003 Nov; 28(6):464-7. PubMed ID: 14631457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. History of major depression is associated with neuropsychiatric symptoms but not systemic inflammation in a cross-sectional study in obese patients.
    Oriolo G; Huet L; Dexpert S; Beau C; Forestier D; Ledaguenel P; Magne E; Martin-Santos R; Capuron L
    Brain Behav Immun; 2019 Feb; 76():215-222. PubMed ID: 30476563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.